EFFECT OF NIFEDIPINE ON SERUM DIGOXIN CONCENTRATION AND RENAL DIGOXIN CLEARANCE

被引：45
作者：
SCHWARTZ, JB
MIGLIORE, PJ
机构：
[1] BAYLOR COLL MED,DEPT PATHOL,CLIN PHARMACOL HYPERTENS SECT,HOUSTON,TX 77030
[2] BAYLOR COLL MED,DEPT INTERNAL MED,HOUSTON,TX 77030
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 01期
关键词：
D O I：
10.1038/clpt.1984.133
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：19 / 24
页数：6
相关论文
共 50 条
[21]   EFFECT OF SPIRONOLACTONE ON THE RENAL CLEARANCE OF DIGOXIN IN DOGS [J].
OBRIEN, MS ;
SALAMONE, LF ;
GIBSON, TP .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 234 (01) :190-194
[22]   DRUG-INDUCED CHANGES IN SERUM DIGOXIN CONCENTRATION (SDC) AND DIGOXIN CLEARANCE (CD) IN DOGS [J].
WILKERSON, RD ;
MOCKRIDGE, PB ;
MASSING, GK .
FEDERATION PROCEEDINGS, 1980, 39 (03) :746-746
[23]   NIFEDIPINE DOES NOT ALTER DIGOXIN LEVEL OR CLEARANCE [J].
SCHWARTZ, JB ;
MIGLIORE, PJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (02) :478-478
[24]   DIGOXIN CONCENTRATION IN SERUM [J].
LARBIG, D ;
KOCHSIEK, K .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (21) :853-&
[25]   MATURATION AND RENAL DIGOXIN CLEARANCE [J].
LINDAY, LA ;
ENGLE, MA ;
REIDENBERG, MM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (06) :735-738
[26]   DETERMINANTS OF RENAL CLEARANCE OF DIGOXIN [J].
HALKIN, H ;
SHEINER, LB ;
PECK, CC ;
MELMON, KL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (04) :385-394
[27]   SERUM DIGOXIN CONCENTRATION [J].
WOODCOCK, BG .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (01) :36-36
[28]   DIGOXIN SERUM CONCENTRATION IN SERUM [J].
BODEM, G ;
GILFRICH, HJ .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (15) :632-+
[29]   PREDICTION OF DIGOXIN CLEARANCE PRIOR TO OBTAINING SERUM DIGOXIN LEVELS [J].
HARTER, JG ;
TYSON, MD ;
SCHUSTER, BG ;
NICHOLS, AI ;
PECK, CC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) :199-199
[30]   SERUM DIGOXIN CONCENTRATION IN A NEONATE WITH RENAL AND HEPATIC IMPAIRMENT [J].
TI, TY ;
LEE, HS ;
TAN, CL .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1990, 26 (03) :164-165
12345